Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2004
05/12/2004EP0891346B1 Dihydrobenzofuran compounds useful as anti-inflammatory agents
05/12/2004EP0871451B1 Composition comprising plant stanol esters and the use thereof for lowering the serum cholesterol
05/12/2004EP0815240B1 Novel human cyclin-dependent kinase-like proteins and methods of using the same
05/12/2004EP0781092B1 Nucleic acid encoding adenovirus e1a polypeptide for sensitizing tumor cells to chemotherapy or irradiation
05/12/2004CN1496408A Glucosamine and method of making glucosamine from microbial biomass
05/12/2004CN1496405A Processer for enhanced production of pantothenate
05/12/2004CN1496404A Materials and methods relating to protein aggregation in neurodegenerative disease
05/12/2004CN1496366A Triazolopyridines as anti-inflammatory agents
05/12/2004CN1496364A Substituted quinazoline derivatives and their use as inhibitors
05/12/2004CN1496363A Process for preparation of imidazole compounds
05/12/2004CN1496362A Non-imidazole compounds as histamine H3 antagonists
05/12/2004CN1496361A 苯基衍生物3 Phenyl derivative 3
05/12/2004CN1496360A Imidazolidine derivatives, their preparation, and their use as antinflamatory agent
05/12/2004CN1496354A Quinoline, isoquinoline and phthalazine derivatives as antagonists of gonadotropin-releasing hormone
05/12/2004CN1496352A Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-yl methyl]-amines and use of same as analgesics
05/12/2004CN1496351A 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives
05/12/2004CN1496350A Improved process for preparing pure ondansetron hydrochloride dihydrate
05/12/2004CN1496349A (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane, compositions and uses thereof
05/12/2004CN1496348A 5-cyano-1H-indole derivatives as antagonists of interleukine-8 receptors
05/12/2004CN1496347A Biguanide derivatives
05/12/2004CN1496275A Transdermal electrotransport device and method for mfg. same
05/12/2004CN1496271A Method of treating diseases in association with decrease in expression of AOP-1 gene or AOP-1 and remedies for diseases
05/12/2004CN1496270A Pharmaceutical composition based on macrolides for topical application in ophthalmology
05/12/2004CN1496267A Preventives for microbial infections
05/12/2004CN1496265A Medicine for fighting against sexual dysfunction
05/12/2004CN1496264A 4-fluoro-N-indan-2-Y1 benzamide and its use as pharmaceutical
05/12/2004CN1496263A Use of anfigestagens for inhibiting accelerated endometrial maturation during infertility treatment
05/12/2004CN1496262A Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists
05/12/2004CN1496261A Remedies and/or preventives for diabetic ischemic heart diseases
05/12/2004CN1496260A Method for increasing leptin levels using nicotinic acid compounds
05/12/2004CN1496259A New use
05/12/2004CN1496258A Methods of administering epothilone analogs for treatment of cancer
05/12/2004CN1496257A Benzimidazole compounds for modulating igE and inhibiting cellular proliferation
05/12/2004CN1496256A Combination of EPOTHILONE analogs and chemotherapeutic agents for treatment of proliferative diseases
05/12/2004CN1496255A Inhibition of NF-KB by triterpene compositions
05/12/2004CN1496254A Treatment of male sexual dysfunction
05/12/2004CN1496253A 新组合物 The new composition
05/12/2004CN1496241A Radiation cross-linked hydrogels
05/12/2004CN1495254A Using phenylethyl caffeiate derivative, capsaicin and resin toxin to inhibit NF-KB
05/12/2004CN1495194A Application of steroid saponin for preventing and curing senile dementia and new steroid saponin
05/12/2004CN1495184A Substituted purine derivative, its preparation method, application and composition containing it
05/12/2004CN1495183A Para-herqueinamide as medicine for resisting parasite
05/12/2004CN1495182A Substituted diindolyl maleimide for inhibiting cell proliferation
05/12/2004CN1495181A Method for preparing cyclic oxazolidone containing sulfur and fluorine
05/12/2004CN1495177A C-10 position paclitaxane derivative and its medicine composition
05/12/2004CN1495174A Preparation method of isoxazolylalkyldione compound
05/12/2004CN1495172A Irreversible inhibitor of tyrosine kinase
05/12/2004CN1495171A Indazol compound for inhibiting protein kinase and medicine composition and their application
05/12/2004CN1495170A Substituted pyrazolyl benzsulfamide compound for curing inflammation
05/12/2004CN1495169A Pyridine-3-carboxylic acid derivative
05/12/2004CN1495167A New preparation method of pesticide intermediate
05/12/2004CN1495166A Organic acid salt of amlodipine
05/12/2004CN1495165A Indane or indoline derivative
05/12/2004CN1495163A Novol pyrrole sulphamide compound
05/12/2004CN1495160A I-substituted-1-aminomethyl-cycloalkane derivative (gabapentin analogs), its preparation and application for curing neuropathy
05/12/2004CN1495157A Preparation method of cyanophthaofluoroaniline
05/12/2004CN1495152A Germifuga and cosmetics and clothes using it
05/12/2004CN1494916A Chinese medicine composition for promoting bllod circulation and its preparation method
05/12/2004CN1494913A Application of polygonatum polyscaccharide
05/12/2004CN1494912A Method for curing diseases related to cell factor
05/12/2004CN1494911A Slowly-reteased preparation of erythromycin derivative
05/12/2004CN1494910A Medicine containing pulsatilla root extuact as active component for curing solid tumor
05/12/2004CN1494909A Phytosterol and/or plant steroid alkanol derivative
05/12/2004CN1494908A Stable tibolone composition
05/12/2004CN1494907A Drug composition for curing pain
05/12/2004CN1494906A Application of compound in preparation of medicine for preventing and curing multiple drug resistance
05/12/2004CN1494905A Medicine composition containing anti-tumor medicine and hydroximic acid derivative and having anti-tumor enhanced acitity and/or reducing side effect
05/12/2004CN1494904A Inhibitor for inhibiting cell adhesion
05/12/2004CN1494903A Preventing or curing agent for eye fatigue and pseudomyopia
05/12/2004CN1494902A Application of high-solubility berberine in preparation of medicine.
05/12/2004CN1494900A Slow releasing composition and its preparing method
05/12/2004CN1494899A Slowly-released dosage form containing asperline
05/12/2004CN1494898A Valacycloguanosine tablet containing colloid silica
05/12/2004CN1494829A Antimicrobial additive and ink composition containing said additive
05/12/2004CN1149223C Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
05/12/2004CN1149222C Preparation of furoic acid momisone
05/12/2004CN1149220C Bromotiacumicin cpmpounds
05/12/2004CN1149219C New compounds for treatment of cancer
05/12/2004CN1149215C Phenyl Yanthine derivatives
05/12/2004CN1149214C Triazolo gerivatives and chemokine inhibitors containing the same as the active ingredient
05/12/2004CN1149212C Peperidine derivatives as reuptake inhibitors
05/12/2004CN1149210C Thrombin inhibitors
05/12/2004CN1149209C Triazole compounds with dopamine-D3-receptor affinity
05/12/2004CN1149206C Intermediate compound for preparing xibo ketone
05/12/2004CN1149204C 1-heterocycle substd. diarylamines
05/12/2004CN1149201C Novel spiro imidazoline compounds, their prepn. method and medicinal compsns. containing same
05/12/2004CN1149196C Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
05/12/2004CN1149195C 5-HTIF agonists
05/12/2004CN1149193C Substituted tricyclic compound
05/12/2004CN1149192C Process for preparing protected 4-aminomethyl-pyrrolidin-3-one
05/12/2004CN1149191C Azetidine derivatives, Preparation and medicines containing them
05/12/2004CN1149190C Nitric oxide synthase inhibitors
05/12/2004CN1149102C Stabilized preparations of beta-lactam anitbiotic
05/12/2004CN1149088C Bone growth promoting composition and its use
05/12/2004CN1149087C Endothelin antagonist and beta receptor blocking agent as comblined preparation
05/12/2004CN1149086C Medicine for improving optic nerve papilla
05/12/2004CN1149085C Inhibition of RAF kinase using substituted heterocyclic useas
05/12/2004CN1149084C Medicine for treating neurodegenerative disease
05/12/2004CN1149083C Pharmaceutical compositions containing irbesartan
05/12/2004CN1149082C Di-and trivalent small molecule selecting protein inhibitors